Seattle Genetics | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 38.75B 4.31B 2024-12
Acadia Pharmaceuticals USD 302.53M 92.34M 2025-03
Agios Pharmaceuticals USD 52.37M 28.79M 2025-03
Amgen USD 23.01B 91M 2025-03
Astellas Pharma JPY 1.06T 90.95B 2025-03
Bayer EUR 27.96B 993M 2025-03
Biogen USD 5.3B 231.4M 2025-03
BioMarin Pharmaceutical USD 628.21M 21.22M 2025-03
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Celldex Therapeutics USD 32.02M 7.48M 2025-03
Daiichi Sankyo JPY 754.03B 41.68B 2025-03
Eisai JPY 372.29B 9.32B 2025-03
Eli Lilly USD 30.07B 1.69B 2025-03
Exelixis USD 399.1M 4.67M 2025-04
Genmab DKK 756M 4.55B 2025-03
Gilead Sciences USD 12B 279M 2024-12
GlaxoSmithKline GBP 20.83B 866M 2025-03
Glaxosmithkline GBP 21.7B 238M 2024-12
Incyte USD 1.89B 244.96M 2025-03
Insmed USD 239.23M 58.29M 2025-03
MacroGenics USD 55.53M 3.78M 2024-12
Merck USD 25.17B 3.25B 2025-03
Moderna USD 1.6B 602M 2025-03
Novartis USD 28.69B 560M 2024-12
Pfizer USD 36.45B 6.54B 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Sanofi 32.22B 3.06B 2025-03
Sarepta Therapeutics USD 605.59M 126.1M 2025-03
Takeda JPY 2.51T 408.56B 2025-03
Teva Pharmaceutical Industries USD 11.16B 1.64B 2025-03
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12
Xencor USD 88.44M 1M 2025-03



Seattle Genetics Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.